相关实验视频
Updated: Jun 21, 2026

08:49
Models of Bone Metastasis
Published on: September 4, 2012
42.9K
关于长骨转移性疾病的50篇最常被引用的文章:一个图书统计分析
Nicolaas Kotze1,2, Alexander Price3,2, Xander van Heerden2,3
1Department of Trauma & Orthopaedics, St James Hospital, Dublin, Ireland.
Journal of orthopaedics
|December 24, 2025
概括
这项研究分析了对长骨转移性疾病的研究,发现重点是手术管理,但缺乏高级证据和多样化的全球代表性. 未来的研究应该优先考虑强有力的证据和包容性,以改善患者护理.
科学领域:
- 在瘤学瘤学.
- 整形外科手术 整形外科手术
- 图书统计学 图书统计学
背景情况:
- 骨转移,特别是在长骨中,正在增加,需要对当前研究进行审查.
- 关于长骨转移性疾病的现有文献需要评估,以指导未来的研究工作.
- 文献计量分析为评估该领域研究的范围和影响提供了一个框架.
研究的目的:
- 进行关于长骨转移性疾病的研究环境的综合图书统计分析.
- 确定主要的主题领域,出版趋势和研究的地理分布.
- 确定现有文献中的差距,例如缺乏高级证据和多样化的代表性.
主要方法:
- 使用Publish或Perish软件进行了系统的文献搜索,并访问了Google Scholar.
- 关于"长骨转移性疾病"的50篇最多被引用的文章是根据定义的纳入标准进行选择的.
- 分析包括引用指标,研究设计,地理分布和关键词的共同出现,以确定研究主题.
主要成果:
- 自2000年代初以来,出版活动有所增加,与改善的瘤治疗相吻合.
- 大多数顶级文章 (64%) 使用了回顾性队列设计;没有确定随机对照试验.
- 研究集中在北美和西欧 (超过70%),低收入和中等收入国家的贡献很少.
- 关键的研究主题包括手术管理,预后因素和结果/并发症.
结论:
- 目前关于长骨转移性疾病的研究重点集中在手术管理策略上.
- 在高水平的证据 (例如,RCT) 和来自全球不同人口的参与研究方面存在重大差距.
- 未来的研究必须专注于产生强有力的证据,并确保包容性,以改善这种复杂疾病的患者护理.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

